Precipitating antibodies against a complex system of ,-lipoprotein antigens were discovered in some patients who had been transfused with blood. Such antibodies were found more frequently in patients who had been multiply transfused over a period of time, for example patients with hemophilia and thalassannia (Allison & Blumberg 1961 , Blumberg et al. 1962 ). An antibody, which gave a precipitin line with only one serum when tested against a panel of 24 sera, was detected in the serum of 2 American hmmophiliacs. The reacting serum was obtained from an Australian aborigine (Blumberg 1964) . Further investigations showed that this antigen differed from the serum P-lipoproteins and it was therefore named the Australia antigen (Blumberg et al. 1965) . Extensive studies of the distribution of this antigen in normal populations of different geographical regions and amongst patients with a variety of diseases ultimately suggested a relationship between the Australia antigen and viral hepatitis (Blumberg et al. 1967 ). The Australia antigen, also known as Au(l), SH antigen, hepatitis antigen and now described as the 'hepatitis-associated antigen' has since been shown to be closely associated with viral hepatitis, and serum hepatitis in particular, and this has been the subject of many reviews (Blumberg et al. 1969 , Zuckerman 1969 , Zuckerman et al. 1970 .
Nature ofthe Australia Antigen
The Australia antigen is a protein associated with varying amounts of lipid. It is immunologically distinct from normal low density serum lipoprotein and the immunoelectrophoretic mobility of the antigen is similar to a,-globulin. The buoyant density of the antigen as determined by isopyknic banding in density gradient was 1-063 to 1P30 g/cm' in potassium bromide (Alter & Blumberg 1966 ), 1-20 g/cm3 in cesium chloride, 1-16 g/cm' in sucrose and 115 g/cm' in potassium tartrate gradients (Gerin et al. 1969) . Gerin et al. (1969) used the complement-fixing reactivity as a measure of the stability of partially purified Australia antigen and they found the antigen to be unaffected by repeated freezing and thawing, heating at 56°C ovemight or at 60°C for one hour but it was inactivated by 85-100°C. Reactivity of the antigen was unaffected by overnight exposure to ether at 4°C or to 1 % sodium deoxycholate and 1 % Tween 80 ether for one hour and by pretreatment at pH 2-7 for three hours at room temperature. The complement-fixing activity of the antigen was destroyed by pretreatment with 1 % sodium dodecyl sulphate.
No carbohydrate has been found in concentrated and purified preparations of the Australia antigen and, much more significantly, no nucleic acid has so far been identified. Bayer et al. (1968) , Almeida et al. (1969) and others described the morphology of the Australia antigen as visualized in the electron microscope. Pleomorphic spherical particles measuring approximately 20 nm in diameter and elongated tubular structures with a similar diameter but frequently several hundred nanometres in length were found. Dane et al. (1970) , Zuckerman (1970b ), Zuckerman et al. (1970 and Field & Cossart (1970, personal communication) independently found virus-like particles measuring approximately 40 nm in diameter, in addition to the particles previously associated with the Australia antigen, in serum specimens obtained from patients with viral hepatitis (Fig 1) . These larger particles have a more definite virus-like morphology. Dane et al. (1970) suggested that the I 42 nm pafticles may represnt the serum hepatitis virus, whereas the smalkr 20 nm particles and the tubular forms of the Australia antigen are nonifectious virus-coat material.
These biophysical and biochemical findings raise the question of the biological nature of the Australia antigen. This antigen shares a number of characteristics with the group of agents referred to as the 'slow viruses' which are associated with scrapie in sheep, kuru in man , Aleutian disease of mink and mink encephalopathy (Gerin et al. 1969) . However, it also seems likely that the small particls and the tubular forms may represent incomplete virus particles or virus-coat protein. Alternatively, the Australia antigen may be a protein which is produced speifically by the liver in trponse to infection by the virus of hepatitis. Whether the larger approximately 40 nm particle is a typical virus mus await further intensive studies inluding cultivation in tissue culture. Attempts to culture the Australia antigen in a variety of primary and continuous cell es have not been successful so far, and although enouragng prelimary reslts have bee obtained using cltures ofdiffentiated human liver cells considerable further work is still reqired (Zuckermn 1969).
Laboratory Testsfor the Australia Antigen The two-dimensional micro-Ouchterlony immunodiffusion test is by far the simplest way of detecting the Australia antigen (Blumberg & Riddell 1963 , Prince 1968 ) but it is also the least sensitive method. Other tests include the complement-fixation test , electron microscopy , immunoelectrophoresis (Pesendorfer et al. 1970) , and fluorescent antibody techniques (Millman et al. 1969 , Coyne et al. 1970 , Nowoslawski et al. 1970 . Laboratory methods which are being developed include the platelet aggregation test and radioimmunoassay.
Significance ofthe Australia Antigen
The association between the Australia antigen and hepatitis has at long last provided a specific terologicaL. test for at least some cases of viral hepatitis. However, many discrepacies and indeed conflicting resu have been reported on the specificity of the Australia antigen. In a number of studies the antigen was found to be associated with both the infectious (epidemi) and serum varieties of hepatitis. Many other investigators have demonstrated that the Australia antigen is associated more speifically with the serum hepitis type of infection. Furthermore, consideable epidcniological evidence and many experimental data obtained from the early and more recent human volunteer transmission studies support the contention that infectious hepatitis and serum hepatitis are caused by immunologicllydistinctetiological agents (reviewed by Zuckerfan 1970a). Immunopathogenesis ofSerum Hepatitis Hotchin (1962 Hotchin ( , 1966 postulated an immunological basis for the pathogenesis of serum hepatitis and Hotchin & Collins (1964) compared this type of hepatitis with lymphocytic choriomeningitis in mice and with kuru in man. It was suggested that in serum hepatitis breakdown of tolerance to the infectious agent leads to a Type 4 hypersensitivity reaction resulting in damage to the hepatic cells containing the virus. Steiner et al. (1961) proposed that the hepatocellular damage in hepatitis is mediated by antigen-antibody complexes as in Type 3 hypersensitivity reactions. Popper et al. (1965) considered this as a possible mechanism in chronic active hepatitis. In experimental animals, however, circulating antigenantibody complexes produce more severe lesions in the renal glomeruli than in the liver. Conrad et al. (1964) found nonspecific inflammatory changes in renal biopsies obtained from patients with viral hepatitis, indicating that further work along these lines is required. Barker et al. (1969 and Taylor et al. (1969) noted the presence of circulating immune complexes in the blood of some patients with acute and chronic hepatitis. These observations were subsequently confirmed in the electron microscope by supporting the contention that there may be a number of similarities between the Australia antigen (serum) hepatitis and Type 3 hypersensitivity reactions. It was again proposed that the severity of the disease may depend on the balance between antigen and antibody.
Looking Ahead
The discovery of the association between the Australia antigen and serum hepatitis has been a remarkable advance in the apparently insoluble and frustrating problem of human hepatitis but detailed studies of the biological properties of this antigen are still required. One of the many remaining problems is the cultivation in vitro of the agents causing hepatitis since only then will it be possible to characterize and fully understand these infectious agents.
Summary
The Australia antigen is a protein with a varying amount of lipid and it is more specifically associated with serum hepatitis. Some of the biophysical and biochemical properties of the antigen are described and the presence in serum containing the Australia antigen of three distinct morphological structures, small pleomorphic spherical particles (approximately 20 nm in diameter), tubular forms and larger roughly spherical particles (approximately 40 nm in diameter) is noted. The morphology of the larger particle is more akin to recognized virus structure. The hypothesis of an immunological basis for the genesis of hepatocellular damage in some cases of serum hepatitis is briefly discussed.
